Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash (Q37340624)
Jump to navigation
Jump to search
scientific article published on 21 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash |
scientific article published on 21 January 2009 |
Statements
1 reference
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash (English)
1 reference
Carol Aghajanian
1 reference
Russell J Schilder
1 reference
Harsh B Pathak
1 reference
Anna E Lokshin
1 reference
Robert W Holloway
1 reference
Ronald D Alvarez
1 reference
Hua Min
1 reference
Karthik Devarajan
1 reference
Eric Ross
1 reference
Charles W Drescher
1 reference
Andrew K Godwin
1 reference
21 January 2009
1 reference
1 reference
21-27
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference